{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:00:21Z","timestamp":1790470821135,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijbiomac.2026.153540","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:54:39Z","timestamp":1784044479000},"page":"153540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-carcinoembryonic antigen conjugated resveratrol\/sunitinib-loaded polymeric nanoparticles for therapeutic enhancement in colorectal cancer"],"prefix":"10.1016","volume":"377","author":[{"given":"Punnida","family":"Nonsuwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyanut","family":"Insawang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattarika","family":"Niwetbowornchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seri","family":"Taya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchawan","family":"Srisawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paweena","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattika","family":"Saengkrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primana","family":"Punnakitikashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0005","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2019.01.006","article-title":"Tumor targeting peptides: novel therapeutic strategies in glioblastoma","volume":"47","author":"Raucher","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7782","key":"10.1016\/j.ijbiomac.2026.153540_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153540_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s41048-018-0079-6","article-title":"Co-encapsulation of curcumin and doxorubicin in albumin nanoparticles blocks the adaptive treatment tolerance of cancer cells","volume":"5","author":"Motevalli","year":"2019","journal-title":"Biophys. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12935-022-02561-7","article-title":"A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities","volume":"22","author":"Moutabian","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/nu18020313","article-title":"The multidirectional biological activity of resveratrol: molecular mechanisms, systemic effects and therapeutic potential\u2014a review","author":"Kogut","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fphar.2018.00530","article-title":"Anticancer activity and mechanism of xanthohumol: a prenylated flavonoid from hops (Humulus lupulus L.)","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10555-023-10126-x","article-title":"Resveratrol as sensitizer in colorectal cancer plasticity","volume":"43","author":"Brockmueller","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107128","article-title":"Sunitinib malate inhibits intestinal tumor development in male ApcMin\/+ mice by down-regulating inflammation-related factors with suppressing \u03b2-cateinin\/c-Myc pathway and re-balancing Bcl-6 and Caspase-3","volume":"90","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12935-019-0906-y","article-title":"Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms","volume":"19","author":"Honari","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1520881","article-title":"Exploring the anti-metastatic potential of sunitinib and novel analogs in colorectal cancer: insights into HIF-1\u03b1 mediated metastasis","volume":"16","author":"Rassouli","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153540_bb0075","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.241817","article-title":"Synergistic anticancer activity of resveratrol-loaded polymeric nanoparticles and sunitinib in colorectal cancer treatment","volume":"12","author":"Nonsuwan","year":"2025","journal-title":"R. Soc. Open Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153540_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/jir.2022.0172","article-title":"Analysis of immune and inflammatory microenvironment characteristics of noncancer end-stage liver disease","volume":"43","author":"Wang","year":"2023","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.810572","article-title":"A novel inflammation-related lncRNAs prognostic signature identifies LINC00346 in promoting proliferation, migration, and immune infiltration of glioma","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0090","article-title":"Resveratrol loaded self-nanoemulsifying drug delivery system (SNEDDS) for pancreatic cancer: formulation design, optimization and in vitro evaluation","volume":"64","author":"Md","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.153540_bb0095","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/bph.14664","article-title":"Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity","volume":"176","author":"Zhao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0110","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153540_bb0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153540_bb0120","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.21037\/tcr.2020.03.03","article-title":"Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells","volume":"9","author":"Xiao","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.153540_bb0125","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2217\/nnm-2016-0194","article-title":"Targeted nanoparticles for colorectal cancer","volume":"11","author":"Cisterna","year":"2016","journal-title":"Nanomedicine (London)"},{"issue":"1-2","key":"10.1016\/j.ijbiomac.2026.153540_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijpharm.2018.08.016","article-title":"Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells","volume":"549","author":"Pereira","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0135","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.118.254441","article-title":"Impact of CEA-targeting nanoparticles for drug delivery in colorectal cancer","volume":"370","author":"Sousa","year":"2019","journal-title":"J. Pharmacol. Exper. Ther."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153540_bb0140","doi-asserted-by":"crossref","first-page":"2409635","DOI":"10.1002\/smll.202409635","article-title":"Antibody-nanoparticle conjugates in therapy: combining the best of two worlds","volume":"21","author":"Adhikari","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119305","article-title":"Folate decorated polymeric micelles for targeted delivery of the kinase inhibitor dactolisib to cancer cells","volume":"582","author":"Shi","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153540_bb0150","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s13346-023-01310-1","article-title":"Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy","volume":"13","author":"Priwitaningrum","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1520078","article-title":"Nanoparticle accumulation and penetration in 3D tumor models: the effect of size, shape, and surface charge","volume":"12","author":"Cybulski","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153540_bb0165","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1021\/acs.molpharmaceut.0c00242","article-title":"Drug loading in poly(butyl cyanoacrylate)-based polymeric microbubbles","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"issue":"68","key":"10.1016\/j.ijbiomac.2026.153540_bb0170","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.18632\/oncotarget.25993","article-title":"Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells","volume":"9","author":"Chung","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0175","doi-asserted-by":"crossref","first-page":"36855","DOI":"10.1038\/srep36855","article-title":"Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity","volume":"6","author":"Khaleel","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fonc.2020.00383","article-title":"Resveratrol sensitizes colorectal cancer cells to cetuximab by connexin 43 upregulation-induced Akt inhibition","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153540_bb0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/cr.2014.112","article-title":"Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0190","first-page":"719","article-title":"Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials","volume":"7","author":"Kim","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0200","first-page":"25","article-title":"Resveratrol downregulates PI3K\/Akt\/mTOR signaling pathways in human U251 glioma cells","volume":"8","author":"Jiang","year":"2009","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2026.156491","article-title":"PI3K\/Akt\/mTOR signaling pathway: The major signal transduction involved in the anticancer effects of resveratrol","volume":"283","author":"Jiang","year":"2026","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153540_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s44164-023-00059-8","article-title":"3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response","volume":"2","author":"Senrung","year":"2023","journal-title":"In Vitro Model"},{"issue":"78","key":"10.1016\/j.ijbiomac.2026.153540_bb0215","doi-asserted-by":"crossref","first-page":"74254","DOI":"10.1039\/C6RA15408E","article-title":"Resveratrol loaded PLGA:d-\u03b1-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy","volume":"6","author":"Vijayakumar","year":"2016","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153540_bb0220","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/mnfr.200500010","article-title":"Metabolism and bioavailability of trans-resveratrol","volume":"49","author":"Wenzel","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13318-021-00671-7","article-title":"Population pharmacokinetics of sunitinib and its active metabolite SU012662 in pediatric patients with gastrointestinal stromal tumors or other solid tumors","volume":"46","author":"Wang","year":"2021","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153540_bb0230","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jsps.2018.03.009","article-title":"Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells","volume":"26","author":"Nassir","year":"2018","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1208\/s12249-017-0826-x","article-title":"Anticancer efficacy of self-nanoemulsifying drug delivery system of sunitinib malate","volume":"19","author":"Alshahrani","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121605","article-title":"The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential","volume":"618","author":"Robertson","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0245","first-page":"86","article-title":"Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery","volume":"14","author":"Cao","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.153540_bb0250","article-title":"A biocompatible tea polyphenol nanoplatform for efficient cytosolic delivery of protein therapeutics","volume":"388","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0255","article-title":"Development and evaluation of letrozole-loaded hyaluronic acid\/chitosan-coated poly(d,l-lactide-co-glycolide) nanoparticles","volume":"17","author":"Radwan","year":"2021","journal-title":"J. Pharm. Innov."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153540_bb0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/bios11100392","article-title":"On-site detection of carcinoembryonic antigen in human serum","volume":"11","author":"Mahmoudi","year":"2021","journal-title":"Biosensors"},{"issue":"null","key":"10.1016\/j.ijbiomac.2026.153540_bb0265","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.2147\/DDDT.S505682","article-title":"Mannosamine-engineered nanoparticles for precision rifapentine delivery to macrophages: advancing targeted therapy against Mycobacterium tuberculosis","volume":"19","author":"Luan","year":"2025","journal-title":"Drug Design, Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0270","article-title":"Release mechanisms of PLGA-based drug delivery systems: a review","volume":"10","author":"Siepmann","year":"2025","journal-title":"Int. J. Pharm. X"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.153540_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38165","article-title":"The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0280","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijbiomac.2015.10.079","article-title":"Sunitinib loaded chitosan nanoparticles formulation and its evaluation","volume":"82","author":"Joseph","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153540_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ma14061382","article-title":"Encapsulation and enhanced release of resveratrol from mesoporous silica nanoparticles for melanoma therapy","volume":"14","author":"Marinheiro","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0290","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jconrel.2020.08.019","article-title":"Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats","volume":"327","author":"Yang","year":"2020","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153540_bb0295","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181457","article-title":"Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy","volume":"5","author":"Wan","year":"2018","journal-title":"R. Soc. Open Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0300","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12951-023-02126-4","article-title":"scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells","volume":"21","author":"Silveira","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153540_bb0305","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/ja309812z","article-title":"Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency","volume":"135","author":"Lesniak","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0310","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/jcm14093189","article-title":"Carcinoembryonic antigen (CEA): origin, role in oncology, and concentrations in serum and peritoneal fluid","author":"Niedzielska","year":"2025","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153540_bb0315","article-title":"Advances and perspectives in CEA-targeted therapies: from classic biomarker toward actionable therapeutic target","volume":"7","author":"Sun","year":"2026","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153540_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020388","article-title":"Next-generation CEA-CAR-NK-92 cells against solid tumors: overcoming tumor microenvironment challenges in colorectal cancer","volume":"16","author":"Franz\u00e9n","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41120-022-00060-7","article-title":"PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives","volume":"8","author":"Alvi","year":"2022","journal-title":"AAPS Open"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153540_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043158","article-title":"The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153540_bb0340","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3892\/mmr.2014.2406","article-title":"Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1\/S-phase cell cycle arrest and apoptosis through caspase\/cyclin-CDK pathways","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153540_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different targeting ligands-mediated drug delivery systems for tumor therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114505","article-title":"Dual-drug codelivery nanosystems: an emerging approach for overcoming cancer multidrug resistance","volume":"161","author":"Gong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.153540_bb0355","article-title":"Neutrophils-mediated accelerated blood clearance phenomenon in beagles and rats based on the cross-injection of non-PEGylated and PEGylated nanoemulsions","volume":"9","author":"Liu","year":"2025","journal-title":"Int. J. Pharm. X"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153540_bb0360","doi-asserted-by":"crossref","first-page":"12523","DOI":"10.1021\/acsnano.8b07003","article-title":"Accelerated blood clearance of antibodies by nanosized click antidotes","volume":"12","author":"Smith","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153540_bb0365","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09687688.2010.521200","article-title":"Receptor-targeted nanocarriers for therapeutic delivery to cancer","volume":"27","author":"Yu","year":"2010","journal-title":"Mol. Membr. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153540_bb0370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026034859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026034859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:28:06Z","timestamp":1790468886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026034859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0141813026034859"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153540","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-carcinoembryonic antigen conjugated resveratrol\/sunitinib-loaded polymeric nanoparticles for therapeutic enhancement in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153540"}}